Projekt per år
Projektinformation
Beskrivning (abstrakt)
The Rare Cancers Research Group explores the molecular mechanisms associated with cancerogenesis and tumour progression focusing on rare cancers. We aim to identify novel cancer-specific biomarkers and ultimately improve diagnostics and therapies. We are determined to pave the way towards precision medicine to effectively treat rare cancers.
| Akronym | RaCaRe |
|---|---|
| Status | Pågående |
| Gällande start-/slutdatum | 01/01/2018 → … |
Finansiering
- Sarcoma Foundation of America: 41 260,00 €
- Suomen tiedeseura: 12 000,00 €
Projekt
- 1 Slutfört
-
Uudet ennustetekijät ja lääkekohteet pahanlaatuisissa liposarkoomissa
Sihto, H., Jaatinen, J. K., O'Dell, P. & Salmikangas, S. I.
01/01/2017 → 31/12/2019
Projekt: Helsingfors Universitetets treåriga forskningsprojekt
Forskningsresultat
- 4 Artikel
-
Merkel cell polyomavirus is a passenger virus in both poroma and porocarcinoma
Merilainen, A-S., Sihto, H. & Koljonen, V., jan. 2022, I: Journal of Cutaneous Pathology. 49, 1, s. 49-54 6 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgång -
UV-induced local immunosuppression in the tumour microenvironment of eccrine porocarcinoma and poroma
Puttonen, M., Isola, J., Ylinen, O., Böhling, T., Koljonen, V. & Sihto, H., 1 apr. 2022, I: Scientific Reports. 12, 1, 8 s., 5529.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil -
ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival
Jaatinen, J., Veija, T., Salmikangas, M., Böhling, T., Sihto, H. & Koljonen, V., 24 maj 2021, I: PLoS One. 16, 5, 13 s., 0252099.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil